Business, Headlines, Health FDA approved Pfizer Inc. (NYSE:PFE) oncology biosimilar Zirabev Posted onJune 28, 2019June 28, 2019 Pfizer Inc. (NYSE:PFE) said the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The …